Novo Nordisk (NVO) closed at $38.31 in the latest trading session, marking a -1.03% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.17%. Elsewhere, the Dow saw a downswing of 0.26%, while the tech-heavy Nasdaq depreciated by 0.09%. The drugmaker's shares have seen a decrease of 14.6% over the last month, not keeping up with the Medical sector's loss of 0.67% and the S&P 500's loss of 0.24%. The investment community will be paying close attention to the earnings performance of Novo Nordisk in its upcoming release. It is anticipated that the company will report an EPS of $0.81, marking a 20.59% fall compared to the same quarter of the previous year.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.